Acetilcisteína: Una actualización clínica y farmacológica sobre su efecto mucolítico. Estudio de revisión / Acetylcisteine. A clinical and pharmacological actualization with special. Reference to its mucolytic efect
Prensa méd. argent
; 105(10): 667-677, oct 2019. fig, graf
Artigo
em Espanhol
| BINACIS, LILACS
| ID: biblio-1025940
Biblioteca responsável:
AR392.1
ABSTRACT
The authors present a clinical and farmacological evaluation of the effect and safety of N-acetylcysteine in chronic obstructive diseases. The N-actylcysteine (NAC) is a sulphorated amino acid employed as an mucolytic agent. The efficacy and tolerability of oral NAC as compared with other agents was determined, in the mucolytic treatment on mucus hypersecretion and in the management of respiratory tract fluids and sputums from cigarette smokers, and also as a bronchial mucus fluidifying agent. A sistematic review and analysis of the effect of NAC and its effectiveness. In the treatment of acute respiratory disorders in children was determined
Coleções:
Bases de dados internacionais
Base de dados:
BINACIS
/
LILACS
Assunto principal:
Acetilcisteína
/
Bromoexina
/
Mucosa Respiratória
/
Muco
Limite:
Humanos
Idioma:
Espanhol
Revista:
Prensa méd. argent
Assunto da revista:
Medicina
Ano de publicação:
2019
Tipo de documento:
Artigo
País de afiliação:
México
Instituição/País de afiliação:
Hospital de Especialidades de Puebla/MX
/
Hospital de Traumatología y Ortopedia de Puebla/MX
/
Instituto Mexicano del Seguro Social/MX
/
Universidad Autónoma de Durango/MX